Oncology Institute (TOI) Revenue & Revenue Breakdown
Oncology Institute Revenue Highlights
Latest Revenue (Y)
$324.24M
Latest Revenue (Q)
$94.67M
Main Segment (Y)
Health Care, Patient Service
Oncology Institute Revenue by Period
Oncology Institute Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $324.24M | 28.42% |
| 2022-12-31 | $252.48M | 24.37% |
| 2021-12-31 | $203.00M | 8.26% |
| 2020-12-31 | $187.51M | 20.66% |
| 2019-12-31 | $155.41M | 37.33% |
| 2018-12-31 | $113.16M | - |
Oncology Institute generated $324.24M in revenue during NA 2023, up 28.42% compared to the previous quarter, and up 286.53% compared to the same period a year ago.
Oncology Institute Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $94.67M | 10.35% |
| 2023-12-31 | $85.79M | 4.57% |
| 2023-09-30 | $82.03M | 2.26% |
| 2023-06-30 | $80.22M | 5.29% |
| 2023-03-31 | $76.19M | 6.68% |
| 2022-12-31 | $71.42M | 9.92% |
| 2022-09-30 | $64.98M | 6.66% |
| 2022-06-30 | $60.92M | 10.44% |
| 2022-03-31 | $55.16M | 5.46% |
| 2021-12-31 | $52.30M | 0.06% |
| 2021-09-30 | $52.27M | 4.88% |
| 2021-06-30 | $49.84M | 2.60% |
| 2021-03-31 | $48.58M | -74.09% |
| 2020-12-31 | $187.51M | 296.86% |
| 2020-09-30 | $47.25M | -0.06% |
| 2020-06-30 | $47.28M | 7.40% |
| 2020-03-31 | $44.02M | 17.83% |
| 2018-12-31 | $37.36M | - |
Oncology Institute generated $94.67M in revenue during Q1 2024, up 10.35% compared to the previous quarter, and up 132.54% compared to the same period a year ago.
Oncology Institute Revenue Breakdown
Oncology Institute Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Health Care, Patient Service | $213.50M | $166.78M | $124.07M |
| Capitated Revenue | $70.37M | $61.34M | $54.28M |
| Clinical Research Trials And Other Revenue | $6.90M | $6.36M | $6.38M |
| Dispensary Revenue | $103.83M | $79.34M | $72.55M |
| Fee For Service | $143.13M | $105.44M | $69.79M |
Oncology Institute's latest annual revenue breakdown by segment (product or service), as of Dec 23: Health Care, Patient Service (39.70%), Fee For Service (26.62%), Dispensary Revenue (19.31%), Capitated Revenue (13.09%), and Clinical Research Trials And Other Revenue (1.28%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|
| Fee For Service | $34.79M | $72.79M | $36.64M | $33.70M | $31.47M | $28.27M | $25.16M | $20.54M |
| Dispensary Revenue | $39.68M | $54.40M | $25.20M | $24.24M | $21.61M | $18.84M | $20.22M | $18.68M |
| Clinical Research Trials And Other Revenue | $2.53M | $3.62M | $1.60M | $1.68M | $1.82M | $1.51M | $1.59M | $1.43M |
| Capitated Revenue | $17.67M | $37.02M | $16.79M | $16.57M | $16.53M | $16.36M | $13.94M | $14.52M |
| Health Care, Patient Service | $52.45M | $109.81M | $53.43M | $50.27M | $47.99M | $44.63M | $39.11M | $35.06M |
Oncology Institute's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Health Care, Patient Service (35.65%), Dispensary Revenue (26.97%), Fee For Service (23.64%), Capitated Revenue (12.01%), and Clinical Research Trials And Other Revenue (1.72%).
Oncology Institute Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| UHS | Universal Health Services | $14.28B | $3.91B |
| SEM | Select Medical | $6.66B | $1.76B |
| EHC | Encompass Health | $4.80B | $1.30B |
| AGL | agilon health | $4.32B | $1.48B |
| ENSG | Ensign Group | $3.73B | $1.04B |
| BKD | Brookdale Senior Living | $3.02B | $777.54M |
| SGRY | Surgery Partners | $2.74B | $762.10M |
| CANO | Cano Health | $2.74B | $788.07M |
| MD | Pediatrix Medical Group | $1.99B | $504.30M |
| ADUS | Addus HomeCare | $1.06B | $286.92M |
| LFST | LifeStance Health Group | $1.06B | $300.44M |
| PNTG | Pennant Group | $544.89M | $156.91M |
| CCM | Concord Medical Services | $537.40M | $34.94M |
| TOI | Oncology Institute | $324.24M | $94.67M |
| SNDA | Sonida Senior Living | $255.32M | $70.21M |
| JYNT | Joint | $117.70M | $30.26M |
TOI Revenue FAQ
What is Oncology Institute’s yearly revenue?
Oncology Institute's yearly revenue for 2023 was $324.24M, representing an increase of 28.42% compared to 2022. The company's yearly revenue for 2022 was $252.48M, representing an increase of 24.37% compared to 2021. TOI's yearly revenue for 2021 was $203M, representing an increase of 8.26% compared to 2020.
What is Oncology Institute’s quarterly revenue?
Oncology Institute's quarterly revenue for Q1 2024 was $94.67M, a 10.35% increase from the previous quarter (Q4 2023), and a 24.25% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $85.79M, a 4.57% increase from the previous quarter (Q3 2023), and a 20.11% increase year-over-year (Q4 2022). TOI's quarterly revenue for Q3 2023 was $82.04M, a 2.26% increase from the previous quarter (Q2 2023), and a 26.25% increase year-over-year (Q3 2022).
What is Oncology Institute’s revenue growth rate?
Oncology Institute's revenue growth rate for the last 3 years (2021-2023) was 59.72%, and for the last 5 years (2019-2023) was 108.64%.
What are Oncology Institute’s revenue streams?
Oncology Institute's revenue streams in c 23 are Health Care, Patient Service, Capitated Revenue, Clinical Research Trials And Other Revenue, Dispensary Revenue, and Fee For Service. Health Care, Patient Service generated $213.5M in revenue, accounting 39.70% of the company's total revenue, up 28.01% year-over-year. Capitated Revenue generated $70.37M in revenue, accounting 13.09% of the company's total revenue, up 14.72% year-over-year. Clinical Research Trials And Other Revenue generated $6.9M in revenue, accounting 1.28% of the company's total revenue, up 8.58% year-over-year. Dispensary Revenue generated $103.84M in revenue, accounting 19.31% of the company's total revenue, up 30.87% year-over-year. Fee For Service generated $143.13M in revenue, accounting 26.62% of the company's total revenue, up 35.74% year-over-year.
What is Oncology Institute’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Oncology Institute was Health Care, Patient Service. This segment made a revenue of $213.5M, representing 39.70% of the company's total revenue.